Q) Good prognosis seen in – ca rectum.
A) MSI-H
B) MSI-L
C) BRAF
D) KRAS
Rectum
Neoadjuvant Response in Rectal cancer
Q) In Regression of tumour after Neoadjuvant CTRT for rectal cancer are all except
A) Decrease in size
B) Nodal regression
C) Mucosal venous invasion in mri
D) Depth change
Perioperative steroid management in IBD
Q) All are true regarding perioperative management Of IBD on steroid except
a) Minor procedure needs only routine steroidal dose supplementation
b) Major procedures needs Hydrocort 100-150 mg tds
3.Chronic steroid use causing adrenal failure that presents with hypotension, vomiting, fever, lethargy
4.All cases of UC need supraphysiological dose of steroid.
ELAPE (Extra Levator Abdomino perineal Excision)
Q) What is not true about extra levator Abdomino Perineal Resection (APE) (AIIMS 2019)
a) Anal canal dissected from levator
b) Patient in prone jack knife position
c) Specimen is resected en block with sacrum
d) Entire levator is resected along with mesorectum
FAP
Q) False regarding FAP
a) Mean age of development of cancer is 40
b)50% population develop gastric polyp and duodenal adenoma
c) 2nd most common cause of death is desmoid
d)
Cancer lower rectum
Q) False statement about management of cancer rectum
a) Relative to ERUS, pelvic MRI is more accurate in its ability to detect lymph node involvement
b) Rectal cancers located in the upper third of the rectum are exempt from neoadjuvant treatment.
c) TME is typically performed 2-3 weeks after completion of CRT before fibrosis develop
d) ERAS include early mobilization, transition to oral pain control, and resumption of oral food intake
Juvenile Polyposis Coli
Q) In juvenile polyposis coli, all true except
a) SMAD 4 mutation
b) No risk of cancer
c) Polyps most common in ileum
d) Autosomal Dominant with high penetrance